I don't agree that it's undervalued as they officially have no profits. Speculatively speaking though this is a company that will very quickly become undervalued if/when their plans pan out. The second they get paid this will be worth much more than it's at now. The question is what is the likelihood that that will happen? All evidence I've seen so far is in favor of Kalo landing these contracts though and it's a great time to be in the 3rd world medical infrastructure business right now.
The risk/reward ratio is great. IMO it's a great time to start a long position. People who just want to flip for some quick cash won't get much out of this just yet though.
News 
Market Data 
Discover 
